DGX Quest Diagnostics Inc
Price (delayed)
$169.28
Market cap
$18.79B
P/E Ratio
21.76
Dividend/share
$3
EPS
$7.78
Enterprise value
$25.16B
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals
Highlights
Quest Diagnostics's equity has increased by 7% YoY
The revenue has grown by 7% YoY and by 3.5% from the previous quarter
DGX's price to earnings (P/E) is 45% higher than its 5-year quarterly average of 15.0 and 15% higher than its last 4 quarters average of 19.0
Quest Diagnostics's debt has increased by 29% YoY
Key stats
What are the main financial stats of DGX
Market
Valuations
Earnings
Shares outstanding
110.98M
Market cap
$18.79B
Enterprise value
$25.16B
Price to earnings (P/E)
21.76
Price to book (P/B)
2.79
Price to sales (P/S)
1.91
EV/EBIT
18.71
EV/EBITDA
13.69
EV/Sales
2.55
Revenue
$9.87B
Gross profit
$3.24B
Operating income
$1.35B
Net income
$871M
EBIT
$1.35B
EBITDA
$1.84B
Free cash flow
$909M
Per share
Balance sheet
Liquidity
EPS
$7.78
EPS diluted
$7.69
Free cash flow per share
$8.14
Book value per share
$60.73
Revenue per share
$88.45
TBVPS
$49.58
Total assets
$16.15B
Total liabilities
$9.34B
Debt
$6.93B
Equity
$6.78B
Working capital
$223M
Debt to equity
1.02
Current ratio
1.1
Quick ratio
0.85
Net debt/EBITDA
3.47
Margins
Efficiency
Dividend
EBITDA margin
18.6%
Gross margin
32.9%
Net margin
8.8%
Operating margin
13.6%
Return on assets
5.8%
Return on equity
13.1%
Return on invested capital
15.5%
Return on capital employed
9.6%
Return on sales
13.6%
Dividend yield
1.77%
DPS
$3
Payout ratio
38.6%
DGX stock price
How has the Quest Diagnostics stock price performed over time
Intraday
0.05%
1 week
2.19%
1 month
-2.09%
1 year
25.61%
YTD
12.21%
QTD
0.05%
Financial performance
How have Quest Diagnostics's revenue and profit performed over time
Revenue
$9.87B
Gross profit
$3.24B
Operating income
$1.35B
Net income
$871M
Gross margin
32.9%
Net margin
8.8%
DGX's operating income is up by 8% since the previous quarter and by 7% year-on-year
The revenue has grown by 7% YoY and by 3.5% from the previous quarter
The gross profit has increased by 6% YoY and by 3.9% from the previous quarter
The company's operating margin rose by 3.8% QoQ
Growth
What is Quest Diagnostics's growth rate over time
Valuation
What is Quest Diagnostics stock price valuation
P/E
21.76
P/B
2.79
P/S
1.91
EV/EBIT
18.71
EV/EBITDA
13.69
EV/Sales
2.55
DGX's price to earnings (P/E) is 45% higher than its 5-year quarterly average of 15.0 and 15% higher than its last 4 quarters average of 19.0
DGX's EPS is up by 3.5% since the previous quarter and by 2.5% year-on-year
The stock's price to book (P/B) is 16% more than its last 4 quarters average of 2.4 and 7% more than its 5-year quarterly average of 2.6
Quest Diagnostics's equity has increased by 7% YoY
The stock's price to sales (P/S) is 12% more than its 5-year quarterly average of 1.7 and 12% more than its last 4 quarters average of 1.7
The revenue has grown by 7% YoY and by 3.5% from the previous quarter
Efficiency
How efficient is Quest Diagnostics business performance
DGX's return on assets is down by 9% year-on-year
Quest Diagnostics's return on invested capital has decreased by 5% YoY
DGX's ROE is down by 3.7% year-on-year
DGX's return on sales is up by 3% since the previous quarter
Dividends
What is DGX's dividend history
DPS
$3
Dividend yield
1.77%
Payout ratio
38.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Quest Diagnostics financials performed over time
The total assets is 73% greater than the total liabilities
The company's total liabilities rose by 22% YoY
Quest Diagnostics's quick ratio has decreased by 18% YoY and by 17% QoQ
Quest Diagnostics's debt is 2.2% higher than its equity
Quest Diagnostics's debt has increased by 29% YoY
The company's debt to equity rose by 20% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.